D’Arcy, B. M., Swingle, M. R., Papke, C. M., Abney, K. A., Bouska, E. S., Prakash, A., & Honkanen, R. E. (2019). The Antitumor Drug LB-100 is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active Site Catalytic Metals in PPP5C. Mol Cancer Ther.
Citação norma ChicagoD’Arcy, Brandon M., Mark R. Swingle, Cinta M. Papke, Kevin A. Abney, Erin S. Bouska, Aishwarya Prakash, and Richard E. Honkanen. "The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating With the Active Site Catalytic Metals in PPP5C." Mol Cancer Ther 2019.
Citação norma MLAD’Arcy, Brandon M., et al. "The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating With the Active Site Catalytic Metals in PPP5C." Mol Cancer Ther 2019.